Conjugate heptavalent pneumococcal vaccine outcome improvements.
Heptavalent conjugate pneumococcal vaccine (PCV7) is now routinely administered to infants. Medical records from a pediatric outpatient clinic were used to identify two study groups: 1) those born between January 1995-May 1997(controls), 2) those born between April 2000--May 2001 (PCV7 group). The PCV7 group showed a lower incidence of otitis media episodes, clinic visits for fever and respiratory symptoms, antibiotic prescriptions, ceftriaxone use, and hospitalizations (singled sided probabilities).
Balazs
George C
GC
Department of Pediatrics, University of Hawai'i, John A. Burns School of Medicine, Honolulu, HI 96813, USA.
Garcia
Francisco J
FJ
Yamamoto
Loren G
LG
D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D011008:Pneumococcal Infections / Q000517:prevention & control; D022242:Pneumococcal Vaccines; D016896:Treatment Outcome; D014611:Vaccination
D022242:Pneumococcal Vaccines